Patients’ knowledge of their disease states and proper use of their medications—including adherence or non-adherence—play a large role in preventable ED visits. Our pharmacy team has put together some questions to consider when assessing patient understanding, and some clinical pearls regarding disease-specific medication use that can help identify opportunities for education, additional support and optimization of medication therapy.
Assessing patient understanding of chronic diseases and medications.
1. Jahedi L, Downie S, Saini B, Chan H, Bosnic-Anticevich S. Inhaler Technique in Asthma: How Does it Relate to Patients’ Preferences and Attitudes Toward Their Inhalers? J Aerosol Med Pulm Drug Deliv. 2017;30(1):42-52.
2. New Recommendations for Naloxone. Content last reviewed August 2020. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-and-availability/new-recommendations-naloxone
3. Heidenreich P, Biykem B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2022;145(80):e895-e1032.
4. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127-e248.